company tower banner
BTC Europe GmbH Company Logo
Ludipress® stands as an excipient formulated from lactose monohydrate specifically designed for direct tabletting. It integrates the three essential functionalities of a filler, binder, and disintegrant within a convenient, pre-prepared excipient tailored for tablet production via direct compression technology. This white, odorless, and tasteless granulated powder comprises lactose monohydrate, Povidone K30 (Kollidon® 30), and Crospovidone (Kollidon® CL). It is versatile and suitable for use in capsules and tablets. Ludipress® adheres to the quality standards outlined by the Japan Pharmacopeia (JP), United States Pharmacopeia (USP), and European Pharmacopeia (Ph. Eur.), ensuring compliance and reliability in pharmaceutical formulations.

Chemical Name: Lactose Monohydrate, Polyvinyl Pyrrolidone Copolymer

Functions: Binder, Disintegrant, Filler

Dosage Form: Capsules, Tablets

Certifications & Compliance: European Pharmacopeia (Ph. Eur.), Japan Pharmacopeia (JP), United States Pharmacopeia (USP)

    Knowde Enhanced TDS

    Identification & Functionality

    Pharma & Nutraceuticals Functions

    Applications & Uses

    Dosage Form
    Manufacturing Technology

    Properties

    Physical Form

    Regulatory & Compliance

    Packaging & Availability

    Packaging Type
    Regional Availability
    • Europe
    Packaging Information
    • 20KG Fibreboard boxes